SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Covered Calls for Dummies Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hepps who wrote (4903)4/15/2007 4:22:43 PM
From: im a survivor  Read Replies (1) of 5205
 
Agree. And I do play the bigger ones like qcom and etc.... But this is an interesting one to look at.

The news I have been reading has been both positive and negative...some are saying the drug will get fda approval on the 15th, while others say they will have to do further studies.

I look at it like this. Stock is all over the place but was at $5 and ran to I think $25. Currently at $17.75 and you can sell the may $10's for around $2bucks. That is a very nice premium and stock would have to fall alot(it could) to be assigned, but if assigned at $10, adjusted cost basis would be around $7.75 - $8. So, the question is do I want to take very nice premiums in exchange for possibly of having to own DNDN for about $7.75. Then write CC's against it if assigned, and if the PPS and premiums allow for CC's.

Anybody else gonna play this?

I'm still curious on Bridges play I commented on earlier as it seems to guarantee a profit, assuming stock stays within a certain range and I believe the range was from $10 - $30...would like to hear more opinions on it or any opinion on how to play this or if it is a bit too risky.....Bridge, Unc....any of you guys playing this this week?.TIA....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext